The prevalence of diabetes and obesity are a significant public health concern in the United States, with profound implications for millions of Americans. As of 2018, around 34.2 million individuals were diagnosed with diabetes, while an additional 88 million adults were classified as prediabetic, indicating a troubling trend exacerbated by rising obesity rates (Francis, 2021; Liu et al., 2023). Behavioral factors, including smoking, and heavy alcohol consumption are also associated with the prevalence of diabetes and obesity. This study uses geo-spatial county-level data obtained from merging the 2021 CDC PLACES dataset and the 2019 American Community Survey dataset to analyze the roles of smoking, poverty, and binge drinking on the prevalence of obesity and diabetes across the United States. The findings indicate that higher rates of poverty, smoking and alcohol consumption maybe associated with higher rates of obesity, and diversity at the county level. But, the findings of this study also suggest substantial regional variations in these associations.

The authors have declared no competing interest.

This study did not receive any funding

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes